TELA Bio to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 12, 2020

Rhea-AI Summary

TELA Bio, Inc. (NASDAQ: TELA) announced it will report its second quarter financial results for 2020 on August 12, 2020. A conference call and webcast led by management will follow at 4:30 p.m. ET to discuss these results and provide a corporate update. TELA Bio specializes in tissue reinforcement materials aimed at soft tissue reconstruction needs, emphasizing the advantages of its products over existing biologics and synthetic materials. The company’s offerings are backed by robust pre-clinical research.

Positive

• Focus on innovative tissue reinforcement materials addressing unmet soft tissue reconstruction needs.
• Strong backing from quality, data-driven science and extensive pre-clinical research.

Negative

• None.

MALVERN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced that the company will report 2020 second quarter financial results on August 12, 2020. TELA Bio's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. 

Conference Call and Webcast Details
The conference call can be accessed by dialing (855) 548-1219 for participants in the U.S. or Canada and (409) 217-8881 for international callers, using conference ID 6897439. A live and archived webcast of the event can be accessed via the Events & Presentations page of the investor section of TELA's website.

About TELA Bio, Inc.
TELA Bio, Inc. is a commercial stage medical technology company focused on designing, developing, and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. TELA Bio's products are designed to improve on shortcomings of existing biologics and minimize long-term exposure to permanent synthetic material. TELA Bio's portfolio is supported by quality, data-driven science, and extensive pre-clinical research that has consistently demonstrated advantages over other commercially available products.

TELA Bio Contact
Stuart Henderson
Vice President, Corporate Development and Investor Relations
TELA Bio, Inc.
484-320-2930

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com

FAQ

When will TELA Bio report its second quarter financial results for 2020?

TELA Bio will report its second quarter financial results on August 12, 2020.

What time is the TELA Bio conference call regarding financial results?

The conference call will be held at 4:30 p.m. ET on August 12, 2020.

How can I access the TELA Bio conference call?

The conference call can be accessed at (855) 548-1219 for U.S. and Canada participants and (409) 217-8881 for international callers.

What is TELA Bio's focus in the medical technology field?

TELA Bio focuses on designing, developing, and marketing tissue reinforcement materials for soft tissue reconstruction.